Literature DB >> 3916990

Cocarcinogenesis in vitro using Balb/3T3 cells and aromatic hydrocarbon cocarcinogens.

M Atchison1, M L Atchison, B L Van Duuren.   

Abstract

The mouse skin cocarcinogens fluoranthene, pyrene, and undecane were used with the indirect-acting carcinogen, benzo(a)pyrene (BP), and the direct-acting alkylating carcinogen, beta-propiolactone (BPL), in an in vitro transformation assay. Dose response, cytotoxicity, and transformation studies with these compounds were performed with a subclone (A31-1-1) of the Balb/3T3 cell line. Transformation frequencies were found to increase with increasing concentrations of BP used up to 1.0 micrograms/ml or when BPL was used up to 4.0 micrograms/ml. A significant increase (P less than 0.05) in the transformation frequency over that seen with carcinogen alone was observed when cells were exposed to a combination of fluoranthene (4.0 micrograms/ml) and BP (0.063 micrograms/ml) or pyrene (5.0 micrograms/ml) and BP (0.063 micrograms/ml). Thus, the transformation frequency obtained with BP + fluoranthene was 3.8 x 10(-4) compared to 1.2 x 10(-4) when BP was tested alone. Similarly, the transformation frequency using BP + pyrene was 2.8 x 10(-4) vs. 1.2 x 10(-4) when BP was tested alone. Undecane did not exert any cocarcinogenic effect with BP in the dose range tested. In this in vitro assay, no cocarcinogenic effect was observed when BPL was used with any of the above mouse skin cocarcinogens. All cells isolated from transformed foci showed characteristics of transformed cells including anchorage-independent growth.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3916990     DOI: 10.1007/bf00118197

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  13 in total

1.  The role of cell division in the malignant transformation of mouse cells treated with 3-methylcholanthrene.

Authors:  T Kakunaga
Journal:  Cancer Res       Date:  1975-07       Impact factor: 12.701

2.  Identification of some polynuclear aromatic hydrocarbons in cigarette-smoke condensate.

Authors:  B L VAN DUUREN
Journal:  J Natl Cancer Inst       Date:  1958-07       Impact factor: 13.506

3.  A quantitative system for assay of malignant transformation by chemical carcinogens using a clone derived from BALB-3T3.

Authors:  T Kakunaga
Journal:  Int J Cancer       Date:  1973-09-15       Impact factor: 7.396

4.  Cell variants showing differential susceptibility to ultraviolet light--induced transformation.

Authors:  T Kakunaga; J D Crow
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

5.  Carcinogenicity of epoxides, lactones, and peroxy compounds. 3. Biological activity and chemical reactivity.

Authors:  B L Van Duuren; B M Goldschmidt
Journal:  J Med Chem       Date:  1966-01       Impact factor: 7.446

6.  Chemical cocarcinogenesis with the use of a subclone derived from Balb/3T3 cells with catechol as cocarcinogen.

Authors:  M Atchison; C Chu; T Kakunaga; B L Van Duuren
Journal:  J Natl Cancer Inst       Date:  1982-08       Impact factor: 13.506

7.  Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis.

Authors:  B L Van Duuren; B M Goldschmidt
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

8.  Determination of cocarcinogenic activity of benzo[e]pyrene for respiratory tract mucosa.

Authors:  D C Topping; D H Martin; P Nettesheim
Journal:  Cancer Lett       Date:  1981-02       Impact factor: 8.679

9.  Identification of cocarcinogens and their potential mechanisms of action using C3H10T 1/2 CL8 mouse embryo fibroblasts.

Authors:  S Nesnow; S Leavitt; H Garland; T O Vaughan; B Hyatt; L Montgomery; C Cudak
Journal:  Cancer Res       Date:  1981-08       Impact factor: 12.701

10.  Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer.

Authors:  T T PUCK; P I MARCUS; S J CIECIURA
Journal:  J Exp Med       Date:  1956-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.